Duchenne Muscular Dystrophy Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Duchenne Muscular Dystrophy Clinical Trials Market Report Overview
There were a total of 390 Duchenne muscular dystrophy clinical trials conducted as of January 2024. The Duchenne muscular dystrophy clinical trial market research report provides a comprehensive overview of the market across regions and countries (G7 & E7). It also provides insights into the various phases, trial status, and end points status. The report includes information about the sponsor types and the prominent sponsors associated with the trials as well.
Duchenne Muscular Dystrophy Clinical Trials Market Segmentation by Regions
The key regions where Duchenne muscular dystrophy clinical trials are conducted are North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America. As of January 2024, North America accounted for the highest share of the regional landscape. Sponsors conducted more than 35% of the trials in this region.
Duchenne Muscular Dystrophy Clinical Trials Analysis by Regions, 2024 (%)
Buy the Full Report for More Regional Insights into the Duchenne Muscular Dystrophy Clinical Trials Market
Key Regions | · North America
· Europe · Asia-Pacific · Middle East & Africa · South & Central America |
Key Countries | · The US
· The UK · Canada · Italy · Belgium |
Leading Sponsors | · Sarepta Therapeutics Inc
· PTC Therapeutics Inc · BioMarin Pharmaceutical Inc · Nippon Shinyaku Co Ltd · GSK plc |
Key Sponsor Types | · Company
· Institution · Government |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Duchenne Muscular Dystrophy Clinical Trials Market Segmentation by Countries
- Country Insights
The US had the highest number of Duchenne muscular dystrophy clinical trials, as of January 2024. Meanwhile, France had the highest average patient enrollment as of January 2024.
- G7 Countries
Among the G7 (the US, the UK, Germany, France, Italy, Canada, and Japan) countries, Italy had the highest proportion of Duchenne muscular dystrophy to genetic disorders clinical trials as of January 2024.
- E7 countries
Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Turkey had the highest proportion of Duchenne muscular dystrophy to genetic disorders clinical trials as of January 2024.
Duchenne Muscular Dystrophy Clinical Trials Analysis by Countries, 2024 (%)
Buy the Full Report for More Country Insights into the Duchenne Muscular Dystrophy Clinical Trials Market
Duchenne Muscular Dystrophy Clinical Trials Market - Competitive Landscape
A few of the leading sponsors associated with the market are:
- Sarepta Therapeutics Inc
- PTC Therapeutics Inc
- BioMarin Pharmaceutical Inc
- Nippon Shinyaku Co Ltd
- GSK plc
Sarepta Therapeutics Inc. conducted the highest number of Duchenne muscular dystrophy clinical trials in 2024.
Duchenne Muscular Dystrophy Clinical Trials Market Analysis by Sponsors, 2024 (%)
Buy the Full Report for More Sponsor Insights into the Duchenne Muscular Dystrophy Clinical Trials Market
Duchenne Muscular Dystrophy Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the market are companies, institutions, and the government. Out of them, the company segment dominated the market in January 2024.
Duchenne Muscular Dystrophy Clinical Trials Market Analysis by Sponsor Types, 2024 (%)
Buy the Full Report for More Sponsor Type Insights into the Duchenne Muscular Dystrophy Clinical Trials Market
Segments Covered in the Report
Duchenne Muscular Dystrophy Clinical Trials Regional Outlook (2024)
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South and Central America
Duchenne Muscular Dystrophy Clinical Trials Country Outlook (2024)
- The US
- The UK
- Canada
- Italy
- Belgium
Duchenne Muscular Dystrophy Clinical Trials Regional Outlook (2024)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end-point status.
- The report reviews the top companies involved and enlists all trials pertaining to the company.
- The report provides all the unaccomplished trials with reasons for unaccomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Formulate key business strategies with regard to investment.
- Identify prominent locations for conducting clinical trials which saves time and cost.
- Get top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities.
- Understand trial count and enrollment trends by country in the global therapeutics market.
- Interpret the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Understand clinical trial assessment of the indication on a global, regional, and country level.
PTC Therapeutics Inc
BioMarin Pharmaceutical Inc
Nippon Shinyaku Co Ltd
GSK plc
F. Hoffmann-La Roche Ltd
Santhera Pharmaceuticals Holding AG
Thermo Fisher Scientific Inc
Astria Therapeutics Inc
Italfarmaco Holding SpA
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of Duchenne muscular dystrophy clinical trials in January 2024?
North America accounted for the highest number of Duchenne muscular dystrophy clinical trials as of January 2024.
-
Which country conducted the highest number of Duchenne muscular dystrophy clinical trials in January 2024?
The US conducted the highest number of Duchenne muscular dystrophy clinical trials as of January 2024.
-
Which sponsor type was the most prominent in the Duchenne muscular dystrophy clinical trials in January 2024?
As of January 2024, the company sponsor type conducted most of the Duchenne muscular dystrophy clinical trials.
-
Which are the leading sponsors of Duchenne muscular dystrophy clinical trials?
A few of the leading sponsors of Duchenne muscular dystrophy clinical trials are Sarepta Therapeutics Inc, PTC Therapeutics Inc, BioMarin Pharmaceutical Inc, Nippon Shinyaku Co Ltd, and GSK plc, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.